Concepedia

COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway

Ali Mroueh, Walaa Fakih, Adrien Carmona, Antonin Trimaille, Kensuke Matsushita, Benjamin Marchandot, Abdul Wahid Qureshi, Dal-Seong Gong, Cyril Auger, Laurent Sattler,

Journal of Thrombosis and Haemostasis · 2023 · 39 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

Muthiah Vaduganathan, Orly Vardeny, Thomas Michel et al. · New England Journal of Medicine · 2020 · 2.2K citations · Full text

, , +12

Long-term cardiovascular outcomes of COVID-19

Yan Xie, Evan Xu, Benjamin Bowe et al. · Nature Medicine · 2022 · 2.1K citations · Full text

, , +13

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson et al. · Nature Immunology · 2022 · 1K citations · Full text

, , +13

SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS

Gavin Y. Oudit, Zamaneh Kassiri, Chengyu Jiang et al. · European Journal of Clinical Investigation · 2009 · 920 citations · Full text

, , +11

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play

Ty J. Gluckman, Nicole M. Bhave, Larry A. Allen et al. · Journal of the American College of Cardiology · 2022 · 383 citations · Full text

, , +16